Eligo Bioscience
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
9
Funding Rounds
$82.6m
Money raised
Overview
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti***** Lu | - | - | linkedin twitter |
| Xa**** Du****** | - | - | linkedin twitter instagram |
| Lu***** Ma******** | - | - | - |
| Da*** Bi**** | - | - | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| Xa**** Du****** | - | - | linkedin twitter instagram |
| Da*** Bi**** | - | - | linkedin twitter |
| Ed*** He**** | - | - | linkedin twitter |
| Au****** Gr*********** | - | - | linkedin facebook |
| Sa*** Ka** | - | - | linkedin twitter |
| S�******** Gr**** | - | - | linkedin facebook |
| Je********* Le**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Eligo Bioscience has raised a total of $52.7m in funding over 9 rounds.
Key Insights:
- Eligo Bioscience December 2023 Series B Funding Round: $30m
- Eligo Bioscience April 2018 Series A Funding Round: $1.9m
- Eligo Bioscience September 2017 Series A Funding Round: $18m
- Eligo Bioscience July 2015 Seed Funding Round: $2.8m
- Eligo Bioscience funding round, September 2017: $20m
- Eligo Bioscience Grant (money), January 2019: $4.72m
- Eligo Bioscience Grant (money), September 2017: $2m
- Eligo Bioscience Seed round, July 2015: $3.15m
Eligo Bioscience December 2023 Series B Funding Round
$30m
Eligo Bioscience April 2018 Series A Funding Round
$1.9m
Eligo Bioscience September 2017 Series A Funding Round
$18m
Eligo Bioscience July 2015 Seed Funding Round
$2.8m
Eligo Bioscience funding round, September 2017
$20m
Eligo Bioscience Grant (money), January 2019
$4.72m
Eligo Bioscience Grant (money), September 2017
$2m
Eligo Bioscience Seed round, July 2015
$3.15m
Industries
Eligo Bioscience is active in the following industries:
- Therapeutics
- Drug discovery
- Drug development
- Microbiome
- Medical diagnostics
- Probiotics
- Biomedical engineering
- Biopharmaceutical
- Pharmabiotics
- Drug delivery
- Engineering
- Technology
- Synthetic biology
- Biology
- Biotechnology
- Genomics
- Genome editing
- Microbiology
- Health technology